Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label phase 1-b study to evaluate the safety and efficacy of CCX872-B in
patients with pancreatic adenocarcinoma also receiving FOLFIRINOX chemotherapy.